1-O-Tigloyl-1-O-debenzoylohchinal
1-O-Tigloyl-1-O-debenzoylohchinal is an orally active limonoid-type triterpenoid anti-inflammatory and peripheral analgesic agent isolated from the fruits of Melia toosendan. 1-O-Tigloyl-1-O-debenzoylohchinal significantly inhibits acetic acid (HY-Y0319)-induced increase in vascular permeability, λ-Carrageenan (HY-N9470)-induced paw edema, and acetic acid-induced writhing response in mice. 1-O-Tigloyl-1-O-debenzoylohchinal shows no significant analgesic effect in the hot-plate test, and acts mainly on the peripheral rather than the central nervous system. 1-O-Tigloyl-1-O-debenzoylohchinal can be widely used in the research of acute or chronic inflammation, stomachache and other related diseases.
For research use only. We do not sell to patients.
- CAS No.: 122688-84-0
- Formula: C33H42O8
- Molecular Weight:566.68
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
In Vivo
1-O-Tigloyl-1-O-debenzoylohchinal (100 mg/kg; p.o.; single administration) significantly inhibits λ-carrageenan-induced hind paw edema in mice at 2 h and 4 h after carrageenan injection[1].
1-O-Tigloyl-1-O-debenzoylohchinal (100 mg/kg; p.o.; single administration) exerts no significant effect on the hot-plate reaction latency in mice within 120 minutes after administration[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR mice with Inflammation (male or female, 18-22g)[1]
-
Dosage:100 mg/kg
-
Administration:p.o.; single dose
-
Result:Produced a supernatant absorbance value of 0.031 ± 0.023, which represented a significant reduction in vascular permeability compared to the control group (p < 0.01).\nReduced hind paw swelling to 0.43 ± 0.09 mL at 2 hours (p < 0.01) and 0.96 ± 0.19 mL at 4 hours (p < 0.01) compared to the control group; no significant reduction was observed at 6 hours (1.22 ± 0.16 mL).
-
Animal Model:ICR mice with Nociception (male or female, 18-22g)[1]
-
Dosage:100 mg/kg
-
Administration:p.o.; single dose
-
Result:Reduced the number of writhes to 12.4 ± 4.24, resulting in a 46.5% inhibitory ratio (p < 0.05) compared to the control group.\nProduced no significant changes in hot-plate latency at any time point post-administration, with latencies of 20.43 ± 6.09 s at 30 minutes, 20.83 ± 4.78 s at 60 minutes, and 21.22 ± 7.16 s at 120 minutes, which were comparable to baseline and control values.
Chemical Information
-
CAS No. 122688-84-0
-
Molecular Weight 566.68
-
Formula C33H42O8
-
SMILES
C[C@@]12[C@@](O[C@@]3([H])C2=C([C@H](C4=COC=C4)C3)C)([H])[C@@]5([H])[C@]6([H])[C@@]([C@H]1CC=O)([C@H](C[C@H]([C@]6(CO5)C)OC(C)=O)OC(/C(C)=C/C)=O)C
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
1-O-Tigloyl-1-O-debenzoylohchinal Related Classifications
HY-N18124 Related Classifications
Powered by Bioz